Issue

Vol. 64 No. 10: Issue 10

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Stem cell therapy for lung diseases: From fundamental aspects to clinical applications

https://doi.org/10.14715/cmb/2018.64.10.15
Hossein Hosseinirad
Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
Mohsen Rashidi
Faculty of Medicine, Mazandaran University of Medical Sciences Department of Physiology and Pharmacology, Sari Iran
Mehrdad Moosazadeh Moghaddam
Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
Hamid Tebyanian
Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran & Research Center for Prevention of Oral and Dental Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran
Soheila Nouraei
Department of Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Seyed Ali Mirhosseini
Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Mehdi Rasouli
Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Iran
Soheil Habibian
Faculty of Veterinary Medicine, Islamic azad university, Karaj, Iran

Corresponding Author(s) : Hamid Tebyanian

tebyan.hamid@yahoo.com

Cellular and Molecular Biology, Vol. 64 No. 10: Issue 10

Abstract

The respiratory system is a complex group of organs in the human body, all of which are necessary in breathing. Due to its special anatomy and composition, after exposure to various damaging factors such as micro particles, carbon granules and toxic gases, the respiratory system can be affected by a variety of damage without return to its original state. Currently, the prevalence of lung diseases, including asthma, and chronic obstructive pulmonary diseases, such as emphysema, has increased remarkably. New therapeutic approaches are desperately needed to discover regenerative medicine approaches, especially cell therapy. This review summarizes the recent advances in stem cell treatments and the research efforts conducted through the application of stem cell therapy for respiratory system diseases. In particular, researchers have used animal models to gather data about treating lung injury by stem cell transplantation. This review concentrated on the findings about route, timing and adjustment of cell transplantation dose, optimum stem cell type selection and potency marker of cells as therapeutic agents. These factors are essential subjects for approval and clinical transplantation. The current clinical trials aiming at treatment of lung diseases by stem cells are mentioned and discussed.

 

Keywords

Stem cell Therapy Lung diseases Respiratory system.
Hosseinirad, H., Rashidi, M., Moghaddam, M. M., Tebyanian, H., Nouraei, S., Mirhosseini, S. A., Rasouli, M., & Habibian, S. (2018). Stem cell therapy for lung diseases: From fundamental aspects to clinical applications. Cellular and Molecular Biology, 64(10), 92–101. https://doi.org/10.14715/cmb/2018.64.10.15
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Linneberg A, Dam Petersen K, Hahn-Pedersen J, Hammerby E, Serup-Hansen N, Boxall N. Burden of allergic respiratory disease: a systematic review. Clin Mol Allergy 2016; 14.
  2. Balharry D, Sexton K, BéruBé KA. An in vitro approach to assess the toxicity of inhaled tobacco smoke components: Nicotine, cadmium, formaldehyde and urethane. Toxicology 2008; 244:66–76.
  3. Enarson D. Respiratory diseases in the world: realities of today - opportunities for tomorrow. Sheffield: European Respiratory Society; 2013.
  4. Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho S-C, et al. Chronic lung injury in preterm lambs: disordered respiratory tract development. Am J Respir Crit Care Med 1999; 159:945–958.
  5. Johnson ER, Matthay MA. Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv 2010; 23:243–252.
  6. Tuder RM, McGrath S, Neptune E. The pathobiological mechanisms of emphysema models: What do they have in common? Pulm Pharmacol Ther 2003; 16:67–78.
  7. Nejad-Moghaddam A, Panahi Y, Alitappeh MA, Borna H, Shokrgozar MA, Ghanei M. Therapeutic potential of mesenchymal stem cells for the treatment of airway remodeling in pulmonary diseases. Iran J Allergy Asthma Immunol 2015; 14:552.
  8. Yang C, Jiang J, Yang X, Wang H, Du J. Stem/progenitor cells in endogenous repairing responses: new toolbox for the treatment of acute lung injury. J Transl Med 2016; 14.
  9. Rock JR, Hogan BLM. Epithelial Progenitor Cells in Lung Development, Maintenance, Repair, and Disease. Annu Rev Cell Dev Biol 2011; 27:493–512.
  10. Dobbs LG, Johnson MD, Vanderbilt J, Allen L, Gonzalez R. The great big alveolar TI cell: evolving concepts and paradigms. Cell Physiol Biochem 2010; 25:55–62.
  11. Rackley CR, Stripp BR. Building and maintaining the epithelium of the lung. J Clin Invest 2012; 122:2724–30.
  12. Perl A-KT, Wert SE, Loudy DE, Shan Z, Blair PA, Whitsett JA. Conditional Recombination Reveals Distinct Subsets of Epithelial Cells in Trachea, Bronchi, and Alveoli. Am J Respir Cell Mol Biol 2005; 33:455–62.
  13. Giangreco A, Arwert EN, Rosewell IR, Snyder J, Watt FM, Stripp BR. Stem cells are dispensable for lung homeostasis but restore airways after injury. Proc Natl Acad Sci 2009; 106:9286–9291.
  14. Volckaert T, Dill E, Campbell A, Tiozzo C, Majka S, Bellusci S, et al. Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury. J Clin Invest 2011; 121:4409–19.
  15. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964–966.
  16. Zhang M, Malik AB, Rehman J. Endothelial progenitor cells and vascular repair: Curr Opin Hematol 2014; 21:224–8.
  17. Weiss DJ. Concise Review: Current Status of Stem Cells and Regenerative Medicine in Lung Biology and Diseases: Advances in Lung Regenerative Medicine. STEM CELLS 2014; 32:16–25.
  18. Doyle MF, Tracy RP, Parikh MA, Hoffman EA, Shimbo D, Austin JH, et al. Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema. PloS One 2017; 12:e0173446.
  19. Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med 2009; 13:454–71.
  20. Wei J, Blum S, Unger M, Jarmy G, Lamparter M, Geishauser A, et al. Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 2004; 5:477–488.
  21. Yoder MC. Human Endothelial Progenitor Cells. Cold Spring Harb Perspect Med 2012; 2:a006692–a006692.
  22. Ahmed LA, Rizk SM, EL-Maraghy SA. Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats. Biochem Pharmacol 2017; 138:193–204.
  23. Shi Z, Chen Y, Cao J, Zeng H, Yang Y, Chen P, et al. Intratracheal transplantation of endothelial progenitor cells attenuates smoking-induced COPD in mice. Int J Chron Obstruct Pulmon Dis 2017; Volume 12:947–60.
  24. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Prolif 1970; 3:393–403.
  25. Akram KM, Samad S, Spiteri M, Forsyth NR. Mesenchymal Stem Cell Therapy and Lung Diseases. In: Weyand B, Dominici M, Hass R, Jacobs R, Kasper C, editors. Mesenchymal Stem Cells - Basics Clin. Appl. II, vol. 130, Berlin, Heidelberg: Springer Berlin Heidelberg; 2012, p. 105–29.
  26. Ortiz LA, DuTreil M, Fattman C, Pandey AC, Torres G, Go K, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci 2007; 104:11002–11007.
  27. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, et al. Bone marrow–derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005; 33:145–152.
  28. Wecht S, Rojas M. Mesenchymal stem cells in the treatment of chronic lung disease: Mesenchymal stem cells and lung injury. Respirology 2016; 21:1366–75.
  29. Matthay MA, Thompson BT, Read EJ, McKenna DH, Liu KD, Calfee CS, et al. Therapeutic Potential of Mesenchymal Stem Cells for Severe Acute Lung Injury. Chest 2010; 138:965–72.
  30. Babavalian H, Latifi AM, Shokrgozar MA, Bonakdar S, Tebyanian H, Shakeri F. Cloning and expression of recombinant human platelet-derived growth factor-BB in Pichia Pink. Cell Mol Biol Noisy--Gd Fr 2016; 62:45–51.
  31. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. The Lancet 2008; 371:1579–1586.
  32. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, et al. Bone marrow–derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005; 33:145–152.
  33. Reiter J, Drummond S, Sammour I, Huang J, Florea V, Dornas P, et al. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia. Respir Res 2017; 18.
  34. Huang X, Sun K, Zhao YD, Vogel SM, Song Y, Mahmud N, et al. Human CD34+ Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge. PLoS ONE 2014; 9:e88814.
  35. Yang J, Jia Z. Cell-based therapy in lung regenerative medicine. Regen Med Res 2014; 2:7.
  36. Urbanek K, De Angelis A, Spaziano G, Piegari E, Matteis M, Cappetta D, et al. Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model. PloS One 2016; 11:e0158746.
  37. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide. Cell Stem Cell 2008; 2:141–50.
  38. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice. J Immunol 2007; 179:1855–63.
  39. Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Bundoc VG, et al. Bone marrow stromal cells use TGF- to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci 2010; 107:5652–7.
  40. Németh K, Leelahavanichkul A, Yuen PST, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15:42–9.
  41. Ortiz LA, DuTreil M, Fattman C, Pandey AC, Torres G, Go K, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci 2007; 104:11002–11007.
  42. McCarter SD, Mei SHJ, Lai PFH, Zhang QW, Parker CH, Suen RS, et al. Cell-based Angiopoietin-1 Gene Therapy for Acute Lung Injury. Am J Respir Crit Care Med 2007; 175:1014–26.
  43. Hua J, He Z-G, Qian D-H, Lin S-P, Gong J, Meng H-B, et al. Angiopoietin-1 gene-modified human mesenchymal stem cells promote angiogenesis and reduce acute pancreatitis in rats. Int J Clin Exp Pathol 2014; 7:3580.
  44. McCarter SD, Mei SHJ, Lai PFH, Zhang QW, Parker CH, Suen RS, et al. Cell-based Angiopoietin-1 Gene Therapy for Acute Lung Injury. Am J Respir Crit Care Med 2007; 175:1014–26.
  45. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee J-W, et al. Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37. STEM CELLS 2010; 28:2229–38.
  46. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci 2009; 106:16357–16362.
  47. Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Bundoc VG, et al. Bone marrow stromal cells use TGF- to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci 2010; 107:5652–7.
  48. Fang X, Abbott J, Cheng L, Colby JK, Lee JW, Levy BD, et al. Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A 4. J Immunol 2015; 195:875–81.
  49. Lee SH, Cha S-H, Kim C-L, Lillehoj HS, Song J-Y, Lee K-W. Enhanced adipogenic differentiation of bovine bone marrow-derived mesenchymal stem cells. J Appl Anim Res 2015; 43:15–21.
  50. Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009; 57:1192–203.
  51. Janes. The role of bone marrow-derived stem cells in lung regeneration and repair. StemBook 2008.
  52. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101:3722–3729.
  53. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, et al. Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells. Stem Cells 2006; 24:386–98.
  54. Xu F, Hu Y, Zhou J, Wang X. Mesenchymal stem cells in acute lung injury: are they ready for translational medicine? J Cell Mol Med 2013; 17:927–35.
  55. Işık S, Uzuner N, Karaman M, Karaman í–, Kıray M, Kozanoğlu ć°, et al. Effects of Intraperitoneal Injection of Allogeneic Bone Marrow-derived Mesenchymal Stem Cells on Bronchiolitis Obliterans in Mice Model. Iran J Allergy Asthma Immunol 2017; 16:205.
  56. Hyun I. The bioethics of stem cell research and therapy. J Clin Invest 2010; 120:71–5.
  57. Karami A, Tebyanian H, Goodarzi V, Shiri S. Planarians: an In Vivo Model for Regenerative Medicine. Int J Stem Cells 2015; 8:128–33.
  58. Kim E-H. Current applications of adipose-derived stem cells and their future perspectives. World J Stem Cells 2014; 6:65.
  59. Frese L, Dijkman PE, Hoerstrup SP. Adipose Tissue-Derived Stem Cells in Regenerative Medicine. Transfus Med Hemotherapy 2016; 43:268–74.
  60. Ahn Y-C, Kim SW, Hwang SS, Chae Y-G, Lee AS, Jung MH, et al. Optical imaging of subacute airway remodeling and adipose stem cell engraftment after airway injury. Biomed Opt Express 2014; 5:312.
  61. Wen Q. Adipose tissue-derived stem cells attenuate acute lung injury through eNOS and eNOS-derived NO. Int J Mol Med 2013.
  62. Gupta K, Hergrueter A, Owen CA. Adipose-derived stem cells weigh in as novel therapeutics for acute lung injury. Stem Cell Res Ther 2013; 4:19.
  63. Lorenzi W, Gonçalves FDC, Schneider N, Silva í‰F, Visioli F, Paz AH, et al. Repeated systemic administration of adipose tissue-derived mesenchymal stem cells prevents tracheal obliteration in a murine model of bronchiolitis obliterans. Biotechnol Lett 2017; 39:1269–77.
  64. Ali NN, Edgar AJ, Samadikuchaksaraei A, Timson CM, Romanska HM, Polak JM, et al. Derivation of type II alveolar epithelial cells from murine embryonic stem cells. Tissue Eng 2002; 8:541–550.
  65. Coraux C, Nawrocki-Raby B, Hinnrasky J, Kileztky C, Gaillard D, Dani C, et al. Embryonic Stem Cells Generate Airway Epithelial Tissue. Am J Respir Cell Mol Biol 2005; 32:87–92.
  66. Stripp BR, Shapiro SD. Stem cells in lung disease, repair, and the potential for therapeutic interventions: State-of-the-art and future challenges. Am Thoracic Soc; 2006.
  67. Toya SP, Li F, Bonini MG, Gomez I, Mao M, Bachmaier KW, et al. Interaction of a Specific Population of Human Embryonic Stem Cell–Derived Progenitor Cells with CD11b+ Cells Ameliorates Sepsis-Induced Lung Inflammatory Injury. Am J Pathol 2011; 178:313–24.
  68. Oliveira MS. Placental-derived stem cells: Culture, differentiation and challenges. World J Stem Cells 2015; 7:769.
  69. Pritchard S, Hoffman AM, Johnson KL, Bianchi DW. Pregnancy-associated progenitor cells: An under-recognized potential source of stem cells in maternal lung. Placenta 2011; 32:S298–303.
  70. Huang X, Sun K, Zhao YD, Vogel SM, Song Y, Mahmud N, et al. Human CD34+ Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge. PLoS ONE 2014; 9:e88814.
  71. Chang Y, Park SH, Huh J-W, Lim C-M, Koh Y, Hong S-B. Intratracheal Administration of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in a Patient with Acute Respiratory Distress Syndrome. J Korean Med Sci 2014; 29:438.
  72. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2010; 182:693–718.
  73. Badylak SF, Weiss DJ, Caplan A, Macchiarini P. Engineered whole organs and complex tissues. The Lancet 2012; 379:943–952.
  74. Tebyanian H, Karami A, Motavallian E, Aslani J, Samadikuchaksaraei A, Arjmand B, et al. Histologic analyses of different concentrations of TritonX-100 and Sodium dodecyl sulfate detergent in lung decellularization. Cell Mol Biol 2017; 63:46.
  75. Wagner DE, Bonvillain RW, Jensen T, Girard ED, Bunnell BA, Finck CM, et al. Can stem cells be used to generate new lungs? Ex vivo lung bioengineering with decellularized whole lung scaffolds: Ex vivo lung bioengineering. Respirology 2013; 18:895–911.
  76. Wallis JM, Borg ZD, Daly AB, Deng B, Ballif BA, Allen GB, et al. Comparative Assessment of Detergent-Based Protocols for Mouse Lung De-Cellularization and Re-Cellularization. Tissue Eng Part C Methods 2012; 18:420–32.
  77. Huh D, Leslie DC, Matthews BD, Fraser JP, Jurek S, Hamilton GA, et al. A Human Disease Model of Drug Toxicity-Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice. Sci Transl Med 2012; 4:159ra147-159ra147.
  78. Fishman JM, Wiles K, Lowdell MW, De Coppi P, Elliott MJ, Atala A, et al. Airway tissue engineering: an update. Expert Opin Biol Ther 2014; 14:1477–91.
  79. Gonfiotti A, Jaus MO, Barale D, Baiguera S, Comin C, Lavorini F, et al. The first tissue-engineered airway transplantation: 5-year follow-up results. The Lancet 2014; 383:238–244.
  80. Nichols JE, La Francesca S, Vega SP, Niles JA, Argueta LB, Riddle M, et al. Giving new life to old lungs: methods to produce and assess whole human paediatric bioengineered lungs: Bioengineered human lungs. J Tissue Eng Regen Med 2017; 11:2136–52.
  81. Stessuk T, Ruiz MA, Greco OT, Bilaqui A, Ribeiro-Paes MJ de O, Ribeiro-Paes JT. Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years. Rev Bras Hematol E Hemoter 2013; 35.
  82. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685–1693.
  83. Horie S, Masterson C, Devaney J, Laffey JG. Stem cell therapy for acute respiratory distress syndrome: a promising future? Curr Opin Crit Care 2016; 22:14–20.
  84. Matthay MA, Goolaerts A, Howard JP, Woo Lee J. Mesenchymal stem cells for acute lung injury: Preclinical evidence: Crit Care Med 2010; 38:S569–73.
  85. Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, Ayres J, et al. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis: Safety of MSC therapy for IPF. Respirology 2014; 19:1013–8.
  86. Glassberg MK, Minkiewicz J, Toonkel RL, Simonet ES, Rubio GA, DiFede D, et al. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER). Chest 2017; 151:971–81.
  87. Zhang C, Yin X, Zhang J, Ao Q, Gu Y, Liu Y. Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: A case report. Exp Ther Med 2017.
  88. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013; 143:1590–1598.
  89. Moll G, Jitschin R, von Bahr L, Rasmusson-Duprez I, Sundberg B, Lönnies L, et al. Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses. PLoS ONE 2011; 6:e21703.
  90. Tzouvelekis A, Koliakos G, Ntolios P, Baira I, Bouros E, Oikonomou A, et al. Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal. J Transl Med 2011; 9:182.
  91. Liang W, Xia H. Allogeneic Mesenchymal Stem Cells Injections for the Treatment of Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cells Transplant. J Cancer Sci Ther 2012; 04.
  92. Introna M, Rambaldi A. Mesenchymal stromal cells for prevention and treatment of graft-versus-host disease: successes and hurdles. Curr Opin Organ Transplant 2015; 20:72–8.
  93. Comella K, Blas JAP, Ichim T, Lopez J, Limon J, Moreno RC. Autologous Stromal Vascular Fraction in the Intravenous Treatment of End-Stage Chronic Obstructive Pulmonary Disease: A Phase I Trial of Safety and Tolerability. J Clin Med Res 2017; 9:701–8.
  94. de Oliveira HG, Cruz FF, Antunes MA, de Macedo Neto AV, Oliveira GA, Svartman FM, et al. Combined Bone Marrow-Derived Mesenchymal Stromal Cell Therapy and One-Way Endobronchial Valve Placement in Patients with Pulmonary Emphysema: A Phase I Clinical Trial: MSCs Combined with Endobronchial Valves in Emphysema. STEM CELLS Transl Med 2017; 6:962–9.
  95. Cheng S-L, Lin C-H, Yao C-L. Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science. Stem Cells Int 2017; 2017:1–14.
  96. Nejad-Moghaddam A, Ajdari S, Tahmasbpour E, Goodarzi H, Panahi Y, Ghanei M. Adipose-Derived Mesenchymal Stem Cells for Treatment of Airway Injuries in A Patient after Long-Term Exposure to Sulfur Mustard. Cell J Yakhteh 2017; 19:117.
  97. Nejad-Moghaddam A, Ajdary S, Tahmasbpour E, Rad FR, Panahi Y, Ghanei M. Immunomodulatory Properties of Mesenchymal Stem Cells Can Mitigate Oxidative Stress and Inflammation Process in Human Mustard Lung. Biochem Genet 2016; 54:769–83.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 1166 Download : 478

Most read articles by the same author(s)